Navigation Links
HRT Increases Incidence and Deaths from Ovarian Cancer

Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according //to a study published in the Lancet* today.

Results from the Million Women Study, which is the biggest study of its kind in the world, show that over five years there is one extra case of ovarian cancer in every 2,500 women who take HRT. And for every 3,300 women who take HRT, there will be one additional death from ovarian cancer.

The researchers, who are largely funded by Cancer Research UK, estimate that use of HRT since 1991 has resulted in an extra 1,300 cases and 1,000 deaths from ovarian cancer.

The study also suggests that a woman's risk of ovarian cancer returns to a normal level within a few years of stopping HRT.

Ovarian cancer is the fourth most common cancer in women in the UK with almost 7,000 new cases each year. The five year survival rate for the disease is less than 30 per cent which reflects the fact that ovarian cancer is often diagnosed at a late stage.

Lead researcher, Professor Valerie Beral director of Cancer Research UK's epidemiology unit at the University of Oxford, said: "The results of this study are worrying because they show that not only does HRT increase the risk of getting ovarian cancer, it also increases a woman's risk of dying of ovarian cancer.

"This study, along with our previous research, clearly demonstrates the cancer risks of taking HRT."

Previous results from the Million Women Study have linked the use of HRT with breast and endometrial cancer (cancer of the womb lining). Combined with ovarian cancer, these three diseases account for almost 40 per cent of all cancers in women in the UK and 25 per cent of cancer deaths.

The overall incidence of these three cancers in women who take HRT is 31 cases for every 1,000 women over five years. This compares with 19 cases in women who have never taken HRT.
The Million Women Study represents a quarter of all women aged 50 to 64 in the UK. This research involved nearly 950,000 women in that age group. Around a third of the women were taking HRT and a further fifth had taken it in the past. The women were followed up for an average of almost seven years.

The research showed that the risk of ovarian cancer was increased regardless of which kind of HRT the women were taking.

Professor John Toy, Cancer Research UK’s medical director said: "This study clearly shows that taking HRT increases a woman’s chance of getting ovarian cancer and her chances of dying from the disease.

"Considering this alongside the increases in risk for breast and endometrial cancer, women should think very carefully about whether to take HRT. And women who chose to take HRT should aim do so for clear medical need and for the shortest possible time."

Source-Cancer Research UK/
'"/>




Related medicine news :

1. Step Aerobics Increases good cholesterol
2. Gene Increases Cancer Risk
3. Obesity Increases Risk of Cervical Cancer
4. Psoriasis Increases Cancer Risk
5. Treatment For Prostate Cancer Found To Increases Fracture Risk
6. Risk for Cancer Increases In Diabetics
7. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
8. Smoking Increases The Risk Of Developing Tuberculosis Infection
9. Choice Of Treatment Increases Risk Of Death In Kidney Disease
10. Air Pollution Increases Risk For Heart Disease In Women
11. A Protein That Increases Risk Of Tumours
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: